London, UK: The London Biotechnology Show, Europe’s premier platform dedicated to red biotechnology, is set to return for its third annual edition at Excel London on 9 –10 June 2026. Recognised as a flagship gathering for the global biotech community, the show serves as a catalyst for advancing red biotechnology, transforming breakthroughs in biopharmaceuticals, gene and cell therapy, diagnostics, precision medicine, regenerative medicine, and stem cells into tangible applications that are reshaping modern medicine and patient care.

Building on the Success of 2025
The 2025 edition firmly established the London Biotechnology Show as Europe’s Leading gathering for red biotechnology. The show welcomed 2,200+ attendees, 110 exhibitors and sponsors, 90+ expert speakers, 50+ partners, and facilitated 140+ buyer-seller meetings.

Among the distinguished voices who shaped the dialogue were Howard Dawber OBE (Deputy Mayor of London for Business and Growth), Prof. Chris Johnson (Department for Science, Innovation and Technology), Claire Kerridge (MHRA), Jakob E. Larsen (Novo Nordisk), Thomas Balkizas (Microsoft), and Dr. Matthew Howard (AWS). Their insights, along with contributions from global biotech pioneers, added depth and direction to conversations about the future of healthcare.

Exhibition – A Global Marketplace of Innovation
The 2026 exhibition floor is projected to be larger and more dynamic than ever, attracting 150+ sponsors and exhibitors alongside 4,000+ business professionals from 1,800 biotech companies worldwide. The exhibition will showcase the latest breakthroughs across the biotech value chain, from experimental therapies, cutting-edge diagnostics, and regenerative solutions to AI-driven biotech platforms and advanced biomanufacturing systems. Attendees will benefit from live demonstrations, new product launches, and interactive technology showcases that allow them to experience firsthand the innovations poised to transform healthcare. For investors, corporate leaders, and policymakers, the exhibition offers an unrivalled opportunity to engage directly with the companies and institutions driving progress in life sciences.

Conference Highlights & Expert Insights

The London Biotechnology Show 2026 will also feature a robust conference programme designed to deliver both strategic insight and actionable outcomes. Across keynote sessions, panel discussions, and masterclasses, global biotech leaders will examine the latest developments in red biotechnology, including gene editing, regenerative medicine, AI-powered diagnostics, and scalable biomanufacturing. The conference is structured to provide practical takeaways that guide investment, regulatory, and R&D strategies while fostering collaboration across scientific and commercial disciplines. More than a platform for discussion, the programme is designed to spark ideas, generate solutions, and drive meaningful progress in the life sciences sector.

Key highlights include:

  • Startup Scaleup Showcase: Offering early-stage and emerging biotech companies a high-impact platform to present pioneering solutions, connect with investors, and fast-track growth opportunities.
  • Global Biotechnology Awards 2026: A prestigious ceremony celebrating companies, institutions, and entrepreneurs making transformative contributions to life sciences. These awards not only honor excellence but also spotlight technologies addressing the world’s most urgent healthcare challenges.
  • Buyer Program: A curated matchmaking initiative connecting exhibitors and sponsors for targeted one-on-one meetings, driving partnerships, licensing deals, and investment opportunities.

    Strategic Networking for Catalysing Partnerships
    Networking at the London Biotechnology Show 2026 will be both extensive and highly targeted, creating opportunities for meaningful engagement among scientists, startup founders, investors, executives, and policymakers. Through structured matchmaking programmes, curated introductions, and informal networking sessions, participants will be connected with the people and organisations most relevant to their objectives. This approach ensures that every conversation has the potential to lead to collaboration, investment, or innovation. Whether forging relationships with global biotech executives, discovering new partners, or exploring fresh markets, attendees can expect networking opportunities designed to be impactful, efficient, and long-lasting.

The London Biotechnology Show 2026 is set to be the definitive gathering for red biotechnology, uniting industry leaders, researchers, policymakers, and investors to shape the future of healthcare. With its expanded exhibition floor, world-class speakers, prestigious awards, and unrivalled networking initiatives, the event will once again set the benchmark for Europe’s biotech landscape.

Registration is now open. Don’t miss your chance to join the industry’s most influential voices and be part of the breakthroughs shaping tomorrow’s medicine.


Register now and secure your place at Europe’s leading red biotechnology event.